Literature DB >> 11997458

CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation.

Torsten H Schroeder1, Martin M Lee, Patrick W Yacono, Carolyn L Cannon, A Alev Gerçeker, David E Golan, Gerald B Pier.   

Abstract

Immune cells are activated during cellular responses to antigen by two described mechanisms: (i) direct uptake of antigen and (ii) extraction and internalization of membrane components from antigen-presenting cells. Although endocytosis of microbial antigens by pattern recognition molecules (PRM) also activates innate immunity, it is not known whether this involves extraction and internalization of microbial surface components. Epithelial cells on mucosal surfaces use a variety of receptors that are distinct from the classical endocytic PRM to bind and internalize intact microorganisms. Nonclassical receptor molecules theoretically could act as a type of endocytic PRM if these molecules could recognize, bind, extract, and internalize a pathogen-associated molecule and initiate cell signaling. We report here that the interaction between the cystic fibrosis transmembrane conductance regulator (CFTR) and the outer core oligosaccharide of the lipopolysaccharide (LPS) in the outer membrane of Pseudomonas aeruginosa satisfies all of these conditions. P. aeruginosa LPS was specifically recognized and bound by CFTR, extracted from the organism's surface, and endocytosed by epithelial cells, leading to a rapid (5- to 15-min) and dynamic translocation of nuclear transcription factor NF-kappa B. Inhibition of epithelial cell internalization of P. aeruginosa LPS prevented NF-kappa B activation. Cellular activation depended on expression of wild-type CFTR, because both cultured Delta F508 CFTR human airway epithelial cells and lung epithelial cells of transgenic-CF mice failed to endocytose LPS and translocate NF-kappa B. CFTR serves as a critical endocytic PRM in the lung epithelium, coordinating the effective innate immune response to P. aeruginosa infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11997458      PMCID: PMC124502          DOI: 10.1073/pnas.092160899

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Comparative genomics of the human and mouse T cell receptor loci.

Authors:  G Glusman; L Rowen; I Lee; C Boysen; J C Roach; A F Smit; K Wang; B F Koop; L Hood
Journal:  Immunity       Date:  2001-09       Impact factor: 31.745

2.  Cystic fibrosis lung inflammation: early, sustained, and severe.

Authors:  A Cantin
Journal:  Am J Respir Crit Care Med       Date:  1995-04       Impact factor: 21.405

3.  Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway.

Authors:  O Eidelman; M Srivastava; J Zhang; X Leighton; J Murtie; C Jozwik; K Jacobson; D L Weinstein; E L Metcalf; H B Pollard
Journal:  Mol Med       Date:  2001-08       Impact factor: 6.354

4.  Early pulmonary inflammation in infants with cystic fibrosis.

Authors:  T Z Khan; J S Wagener; T Bost; J Martinez; F J Accurso; D W Riches
Journal:  Am J Respir Crit Care Med       Date:  1995-04       Impact factor: 21.405

5.  Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis.

Authors:  M Bédard; C D McClure; N L Schiller; C Francoeur; A Cantin; M Denis
Journal:  Am J Respir Cell Mol Biol       Date:  1993-10       Impact factor: 6.914

6.  Early bacteriologic, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening.

Authors:  S H Abman; J W Ogle; R J Harbeck; N Butler-Simon; K B Hammond; F J Accurso
Journal:  J Pediatr       Date:  1991-08       Impact factor: 4.406

7.  Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.

Authors:  T R Flotte; S A Afione; C Conrad; S A McGrath; R Solow; H Oka; P L Zeitlin; W B Guggino; B J Carter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

8.  The Pseudomonas aeruginosa algC gene encodes phosphoglucomutase, required for the synthesis of a complete lipopolysaccharide core.

Authors:  M J Coyne; K S Russell; C L Coyle; J B Goldberg
Journal:  J Bacteriol       Date:  1994-06       Impact factor: 3.490

9.  Bioelectric properties of cultured monolayers from epithelium of distal human fetal lung.

Authors:  P M Barker; R C Boucher; J R Yankaskas
Journal:  Am J Physiol       Date:  1995-02

10.  Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR.

Authors:  L Zhou; C R Dey; S E Wert; M D DuVall; R A Frizzell; J A Whitsett
Journal:  Science       Date:  1994-12-09       Impact factor: 47.728

View more
  53 in total

Review 1.  Cystic fibrosis in adults: current and future management strategies.

Authors:  Brian M Morrissey; Bettina C Schock; Gregory P Marelich; Carroll E Cross
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667

2.  A lectin S-domain receptor kinase mediates lipopolysaccharide sensing in Arabidopsis thaliana.

Authors:  Stefanie Ranf; Nicolas Gisch; Milena Schäffer; Tina Illig; Lore Westphal; Yuriy A Knirel; Patricia M Sánchez-Carballo; Ulrich Zähringer; Ralph Hückelhoven; Justin Lee; Dierk Scheel
Journal:  Nat Immunol       Date:  2015-03-02       Impact factor: 25.606

3.  The myeloid differentiation factor 88 is dispensable for the development of a delayed host response to Pseudomonas aeruginosa lung infection in mice.

Authors:  M R Power; J S Marshall; M Yamamoto; S Akira; T-J Lin
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

4.  Lipopolysaccharide-induced human enterocyte tolerance to cytokine-mediated interleukin-8 production may occur independently of TLR-4/MD-2 signaling.

Authors:  Tor C Savidge; Paul G Newman; Wei-Hua Pan; Mei-Qian Weng; Hai Ning Shi; Beth A McCormick; Andrea Quaroni; W Allan Walker
Journal:  Pediatr Res       Date:  2005-12-02       Impact factor: 3.756

5.  Whole-Genome Sequence Analysis and Genome-Wide Virulence Gene Identification of Riemerella anatipestifer Strain Yb2.

Authors:  Xiaolan Wang; Chan Ding; Shaohui Wang; Xiangan Han; Shengqing Yu
Journal:  Appl Environ Microbiol       Date:  2015-05-22       Impact factor: 4.792

6.  Acyl chain specificity of the acyltransferases LpxA and LpxD and substrate availability contribute to lipid A fatty acid heterogeneity in Porphyromonas gingivalis.

Authors:  Brian W Bainbridge; Lisa Karimi-Naser; Robert Reife; Fleur Blethen; Robert K Ernst; Richard P Darveau
Journal:  J Bacteriol       Date:  2008-05-02       Impact factor: 3.490

7.  Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection.

Authors:  Fadie T Coleman; Simone Mueschenborn; Gloria Meluleni; Christopher Ray; Vincent J Carey; Sara O Vargas; Carolyn L Cannon; Frederick M Ausubel; Gerald B Pier
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

8.  Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients.

Authors:  Deanna M Green; Kathryn E McDougal; Scott M Blackman; Patrick R Sosnay; Lindsay B Henderson; Kathleen M Naughton; J Michael Collaco; Garry R Cutting
Journal:  Respir Res       Date:  2010-10-08

9.  Caveolin-1 modifies the immunity to Pseudomonas aeruginosa.

Authors:  Mihaela Gadjeva; Catherine Paradis-Bleau; Gregory P Priebe; Raina Fichorova; Gerald B Pier
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

10.  CFTR is a negative regulator of NFkappaB mediated innate immune response.

Authors:  Neeraj Vij; Steven Mazur; Pamela L Zeitlin
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.